ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will address the need for access to critical advanced molecular testing, labor shortages that limit the availability of testing, and other obstacles laboratories face in adopting this technology at asm2014, the 114th General Meeting of the American Society for Microbiology (ASM), in Boston, Massachusetts, May 17-20.
Rheonix will display its Chemical and Reagent Device (CARD) and EncompassMDx™ molecular testing platform. The Rheonix CARD® is a disposable cartridge the size of a credit card that runs multiple samples simultaneously without user intervention. Once a raw sample is placed on the CARD, the automated EncompassMDx platform runs through the process of sample extraction, DNA purification, amplification and detection. The sample-to-result solution eliminates the need for multiple pieces of existing equipment, helping to make the testing process quicker, more efficient, less expensive and less likely to result in human error.
Held at the Boston Convention & Exhibition Center, asm2014 will showcase the central role of microbes in the biosphere by communicating today’s cutting-edge science in the diverse areas of microbiology through a wide range of interactive workshops, scientific sessions and networking events.
Show attendees are invited to stop by booth 747 to talk to the Rheonix team and learn more about the company’s technology.
The company recently received funding from the National Institutes of Health to simplify HIV testing and raised $14 million to launch its first commercial product in 2014.
For more information, visit www.rheonix.com.
About Rheonix: Rheonix Inc. is committed to improving standards of care by making molecular diagnostics available to more people, in more places, more often. Rheonix, through experienced leadership and creative vision, has developed the EncompassMDx™ platform, a highly customizable technology with unmatched versatility and affordability. The platform performs fully automated, complex molecular assays in an easy-to-use and economical format on the Rheonix CARD® cartridge. With both the Rheonix CARD and EncompassMDx family of products, Rheonix is well-positioned to penetrate key molecular diagnostic market sectors, from reference labs through point-of-care and everywhere in between. For more information, visit www.rheonix.com.
Christopher Powers
Public Relations Account Manager
Pinckney Hugo Group
760 West Genesee Street
Syracuse, NY 13204
315-478-6700
cpowers@pinckneyhugo.com
On behalf of Rheonix
Help employers find you! Check out all the jobs and post your resume.
